Related Experiment Video
Updated: May 28, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
ERK inhibits osteoclast differentiation in RAW 264.7 cells through the osteoprotegerin-mediated autophagy
Soo-Young Shin1, In-Soon Kang2, Chaekyun Kim1
1Laboratory of Leukocyte Signaling Research, Department of Pharmacology, College of Medicine, Inha University, Incheon 22212, Republic of Korea; BK21, Program in Biomedical Science and Engineering, Inha University, Incheon 22212, Republic of Korea.
Abstract:
Osteoclasts (OCs) are bone-resorbing cells derived from the monocyte/macrophage lineage. The extracellular signal-regulated kinase (ERK) pathway controls cellular responses such as proliferation, differentiation, and survival, including those of OCs. In the present study, ERK inhibitors reduced the proliferation of bone marrow-derived macrophages (BMMs) and RAW 264.7 cells. However, ERK inhibitors decreased OC differentiation in BMMs but increased it in RAW 264.7 cells. ERK downregulation using small interfering RNA transfection also increased the OC differentiation and the expression of receptor activator of nuclear factor-κB, OC-specific markers, and OC-associated transcription factors in RAW 264.7 cells. These findings suggest ERK regulates OC differentiation in RAW 264.7 cells differently than in BMMs. Thus, we further investigated the mechanism by which ERK negatively regulates OC differentiation in RAW 264.7 cells. ERK inhibition decreased the expression of osteoprotegerin (OPG), a negative regulator of OC differentiation. OPG knockdown increased OC formation. ERK inhibitors activated the Akt/mammalian target of the rapamycin (mTOR) signaling pathway while inhibiting unc-51-like autophagy activating kinase 1 (ULK1). This resulted in decreased levels of microtubule-associated protein 1A/1B-light chain 3-II (LC3-II) and increased levels of p62, thereby reducing autophagy. In addition, OPG knockdown reduced autophagy by activating Akt/mTOR and inhibiting ULK1, resulting in decreased LC3-II and accumulated p62. Therefore, ERK inhibition promoted OC differentiation by downregulating OPG-mediated inhibition of osteoclastogenesis and autophagy in RAW 264.7 cells. These findings highlight ERK's complex role in OC differentiation and suggest that understanding ERK's dual impact on OC differentiation can provide insights into novel treatment strategies for bone-related disorders.
Insights
Extracellular signal-regulated kinase (ERK) pathway impacts osteoclast (OC) differentiation differently in various cells. In RAW 264.7 cells, ERK inhibition promotes OC differentiation by reducing osteoprotegerin and autophagy.
Area of Science:
- Cell Biology
- Molecular Biology
- Bone Biology
Background:
- Osteoclasts (OCs) are crucial for bone resorption, originating from monocytes/macrophages.
- The extracellular signal-regulated kinase (ERK) pathway influences cell proliferation, differentiation, and survival, including OCs.
- ERK's precise role in OC differentiation requires further elucidation due to cell-type-specific effects.
Purpose of the Study:
- To investigate the differential effects of ERK inhibition on OC differentiation in bone marrow-derived macrophages (BMMs) and RAW 264.7 cells.
- To elucidate the underlying molecular mechanisms by which ERK regulates OC differentiation in RAW 264.7 cells.
- To explore the interplay between ERK, osteoprotegerin (OPG), and autophagy in OC differentiation.
Main Methods:
- Treatment of BMMs and RAW 264.7 cells with ERK inhibitors.
- ERK downregulation using small interfering RNA (siRNA) in RAW 264.7 cells.
- Analysis of OC-specific markers, transcription factors, OPG expression, and autophagy-related proteins (LC3-II, p62).
- Investigation of the Akt/mammalian target of the rapamycin (mTOR) and unc-51-like autophagy activating kinase 1 (ULK1) signaling pathways.
Main Results:
- ERK inhibitors reduced BMM proliferation but decreased OC differentiation in BMMs while increasing it in RAW 264.7 cells.
- ERK downregulation in RAW 264.7 cells enhanced OC differentiation and expression of key OC markers.
- ERK inhibition in RAW 264.7 cells decreased OPG expression and autophagy (via Akt/mTOR activation and ULK1 inhibition), promoting OC formation.
- OPG knockdown mimicked the effects of ERK inhibition on autophagy.
Conclusions:
- ERK plays a complex, cell-dependent role in regulating OC differentiation.
- In RAW 264.7 cells, ERK negatively regulates OC differentiation by suppressing OPG expression and autophagy.
- Targeting the ERK pathway may offer novel therapeutic strategies for bone disorders characterized by aberrant OC activity.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway

